Amanote Research

Amanote Research

    RegisterSign In

Concurrent miR-21 Suppression and FXR Activation as a Mechanism of Improvement in Nonalcoholic Fatty Liver Disease

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-018-0386-3
Full Text
Open PDF
Abstract

Available in full text

Categories
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
Date

March 1, 2018

Authors
Guilherme S. MazziniJad KhorakiMatthew G. BrowningGuilherme M. Campos
Publisher

Springer Science and Business Media LLC


Related search

Nonalcoholic Fatty Liver Disease

Hypertension
Internal Medicine
2020English

Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2002English

Nonalcoholic Fatty Liver Disease in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Nonalcoholic Fatty Liver Disease in 2020

Gastroenterology
HepatologyGastroenterology
2020English

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis

Journal of Clinical and Experimental Hepatology
Hepatology
2015English

Ethnicity and Nonalcoholic Fatty Liver Disease

Hepatology
MedicineHepatology
2012English

In Brief: Nonalcoholic Fatty Liver Disease

Pediatrics in Review
MedicineChild HealthPediatricsPerinatology
2010English

Dehydroepiandrosterone in Nonalcoholic Fatty Liver Disease

2012English

Nonalcoholic Fatty Liver Disease: A Pathological View

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy